Digestive changes are common during GLP-1 therapy, and when they reduce intake or tolerance, supportive nutrition strategies may help
The first month is often characterised by adjustment rather than dramatic transformation
Traditionally used in the treatment of type 2 diabetes and obesity, Semaglutide is now being explored for its potential to reduce inflammation, improve mood, and support metabolic healthall without the pronounced side effects of higher doses
Both bone loss and muscle loss are linked to joint problems, research shows
Its easy to assume that a medication like retatrutide is automatically the strongest option because it targets three receptors instead of one or two
Quick Answer: Lightheadedness with tirzepatide typically occurs indirectly through hypoglycemia when combined with other diabetes medications, dehydration from gastrointestinal side effects, or orthostatic hypotension related to weight loss